INSM logo

Insmed Incorporated (INSM) Cash from financing

annual CFF:

$1.34B+$1.17B(+696.15%)
December 31, 2024

Summary

  • As of today (July 12, 2025), INSM annual cash flow from financing activities is $1.34 billion, with the most recent change of +$1.17 billion (+696.15%) on December 31, 2024.
  • During the last 3 years, INSM annual CFF has risen by +$728.47 million (+118.93%).
  • INSM annual CFF is now at all-time high.

Performance

INSM Cash from financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMcash flow metrics

quarterly CFF:

$29.00M-$130.31M(-81.80%)
March 31, 2025

Summary

  • As of today (July 12, 2025), INSM quarterly cash flow from financing activities is $29.00 million, with the most recent change of -$130.31 million (-81.80%) on March 31, 2025.
  • Over the past year, INSM quarterly CFF has increased by +$25.98 million (+859.56%).
  • INSM quarterly CFF is now -96.29% below its all-time high of $781.49 million, reached on June 30, 2024.

Performance

INSM quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMcash flow metrics

TTM CFF:

$1.37B+$25.98M(+1.94%)
March 31, 2025

Summary

  • As of today (July 12, 2025), INSM TTM cash flow from financing activities is $1.37 billion, with the most recent change of +$25.98 million (+1.94%) on March 31, 2025.
  • Over the past year, INSM TTM CFF has increased by +$1.20 billion (+695.41%).
  • INSM TTM CFF is now at all-time high.

Performance

INSM TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherINSMcash flow metrics

Cash from financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

INSM Cash from financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+696.1%+859.6%+695.4%
3 y3 years+118.9%+348.9%+123.3%
5 y5 years+370.1%+1258.9%+418.8%

INSM Cash from financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+696.1%-96.3%+7367.7%at high+6404.6%
5 y5-yearat high+696.1%-96.3%+7367.7%at high+6404.6%
alltimeall timeat high>+9999.0%-96.3%+913.2%at high>+9999.0%

INSM Cash from financing History

DateAnnualQuarterlyTTM
Mar 2025
-
$29.00M(-81.8%)
$1.37B(+1.9%)
Dec 2024
$1.34B(+696.1%)
$159.31M(-59.9%)
$1.34B(+2.8%)
Sep 2024
-
$397.20M(-49.2%)
$1.30B(+43.6%)
Jun 2024
-
$781.49M(>+9900.0%)
$909.03M(+428.9%)
Mar 2024
-
$3.02M(-97.5%)
$171.86M(+2.0%)
Dec 2023
$168.44M(-78.8%)
$123.26M(+9768.9%)
$168.44M(-78.6%)
Sep 2023
-
$1.25M(-97.2%)
$788.56M(-4.4%)
Jun 2023
-
$44.33M(<-9900.0%)
$824.43M(+4.8%)
Mar 2023
-
-$399.00K(-100.1%)
$786.41M(-0.9%)
Dec 2022
$793.27M(+29.5%)
$743.39M(+1902.9%)
$793.27M(+1326.9%)
Sep 2022
-
$37.12M(+488.1%)
$55.60M(+164.5%)
Jun 2022
-
$6.31M(-2.3%)
$21.02M(-96.6%)
Mar 2022
-
$6.46M(+13.1%)
$612.30M(-0.0%)
Dec 2021
$612.55M(+126.0%)
$5.71M(+125.2%)
$612.55M(-1.0%)
Sep 2021
-
$2.54M(-99.6%)
$618.85M(-0.6%)
Jun 2021
-
$597.60M(+8815.4%)
$622.41M(+125.9%)
Mar 2021
-
$6.70M(-44.2%)
$275.57M(+1.7%)
Dec 2020
$271.00M(-5.0%)
$12.01M(+96.8%)
$271.00M(+1.0%)
Sep 2020
-
$6.10M(-97.6%)
$268.23M(+1.8%)
Jun 2020
-
$250.76M(>+9900.0%)
$263.49M(-7.3%)
Mar 2020
-
$2.13M(-76.9%)
$284.36M(-0.3%)
Dec 2019
$285.28M(-26.2%)
$9.24M(+580.3%)
$285.28M(+2.4%)
Sep 2019
-
$1.36M(-99.5%)
$278.46M(+0.3%)
Jun 2019
-
$271.63M(+8808.9%)
$277.71M(+2288.7%)
Mar 2019
-
$3.05M(+25.8%)
$11.63M(-97.0%)
Dec 2018
$386.74M(+1.5%)
$2.42M(+300.5%)
$386.74M(+0.5%)
Sep 2018
-
$605.00K(-89.1%)
$384.75M(-49.5%)
Jun 2018
-
$5.55M(-98.5%)
$762.37M(+0.5%)
Mar 2018
-
$378.17M(>+9900.0%)
$758.69M(+99.1%)
Dec 2017
$381.09M(+1142.4%)
$433.00K(-99.9%)
$381.09M(-5.1%)
Sep 2017
-
$378.22M(>+9900.0%)
$401.51M(+1117.5%)
Jun 2017
-
$1.87M(+230.8%)
$32.98M(+5.8%)
Mar 2017
-
$565.00K(-97.3%)
$31.16M(+1.6%)
Dec 2016
$30.67M(-86.5%)
$20.85M(+115.2%)
$30.67M(+216.8%)
Sep 2016
-
$9.69M(>+9900.0%)
$9.68M(+1089.3%)
Jun 2016
-
$47.00K(-42.0%)
$814.00K(-99.6%)
Mar 2016
-
$81.00K(-158.3%)
$226.41M(-0.6%)
Dec 2015
$227.80M(+97.9%)
-$139.00K(-116.8%)
$227.80M(-2.8%)
Sep 2015
-
$825.00K(-99.6%)
$234.32M(-31.5%)
Jun 2015
-
$225.64M(>+9900.0%)
$341.93M(+194.2%)
Mar 2015
-
$1.48M(-76.9%)
$116.23M(+1.0%)
Dec 2014
$115.09M(+68.1%)
$6.37M(-94.1%)
$115.09M(+5.8%)
Sep 2014
-
$108.44M(<-9900.0%)
$108.75M(+59.7%)
Jun 2014
-
-$60.00K(-117.8%)
$68.11M(-1.0%)
Mar 2014
-
$337.00K(+764.1%)
$68.76M(+0.5%)
Dec 2013
$68.45M(+50.7%)
$39.00K(-99.9%)
$68.45M(-12.8%)
Sep 2013
-
$67.79M(>+9900.0%)
$78.54M(+115.9%)
Jun 2013
-
$596.00K(+2609.1%)
$36.38M(-20.0%)
Mar 2013
-
$22.00K(-99.8%)
$45.48M(+0.1%)
Dec 2012
$45.42M
$10.13M(-60.5%)
$45.42M(+28.8%)
Sep 2012
-
$25.63M(+164.3%)
$35.28M(+266.5%)
Jun 2012
-
$9.70M(<-9900.0%)
$9.62M(<-9900.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$34.00K(+88.9%)
-$63.00K(+26.0%)
Dec 2011
-$50.00K(-78.5%)
-$18.00K(-18.2%)
-$50.00K(+42.9%)
Sep 2011
-
-$22.00K(-300.0%)
-$35.00K(+169.2%)
Jun 2011
-
$11.00K(-152.4%)
-$13.00K(-43.5%)
Mar 2011
-
-$21.00K(+600.0%)
-$23.00K(-90.1%)
Dec 2010
-$233.00K(-108.1%)
-$3000.00(<-9900.0%)
-$233.00K(-49.2%)
Sep 2010
-
$0.00(-100.0%)
-$459.00K(-32.7%)
Jun 2010
-
$1000.00(-100.4%)
-$682.00K(-121.6%)
Mar 2010
-
-$231.00K(+0.9%)
$3.16M(+10.0%)
Dec 2009
$2.88M(-237.7%)
-$229.00K(+2.7%)
$2.88M(+10.1%)
Sep 2009
-
-$223.00K(-105.8%)
$2.61M(+14.7%)
Jun 2009
-
$3.85M(-842.7%)
$2.28M(-210.9%)
Mar 2009
-
-$518.00K(+4.9%)
-$2.06M(-1.7%)
Dec 2008
-$2.09M(-111.5%)
-$494.00K(-11.3%)
-$2.09M(+155.5%)
Sep 2008
-
-$557.00K(+14.6%)
-$818.00K(+213.4%)
Jun 2008
-
-$486.00K(-12.1%)
-$261.00K(-101.5%)
Mar 2008
-
-$553.00K(-171.1%)
$17.27M(-4.7%)
Dec 2007
$18.12M(-65.5%)
$778.00K(>+9900.0%)
$18.12M(+1.9%)
Sep 2007
-
$0.00(-100.0%)
$17.79M(-0.0%)
Jun 2007
-
$17.05M(+5639.7%)
$17.79M(+2278.7%)
Mar 2007
-
$297.00K(-33.0%)
$748.00K(-98.6%)
Dec 2006
$52.50M(+40.5%)
$443.00K(+7283.3%)
$52.50M(-7.0%)
Sep 2006
-
$6000.00(+200.0%)
$56.43M(-0.1%)
Jun 2006
-
$2000.00(-100.0%)
$56.51M(-0.1%)
Mar 2006
-
$52.05M(+1091.6%)
$56.58M(+51.4%)
Dec 2005
$37.38M(+713.1%)
$4.37M(+4863.6%)
$37.38M(-9.2%)
Sep 2005
-
$88.00K(+12.8%)
$41.17M(+0.2%)
Jun 2005
-
$78.00K(-99.8%)
$41.09M(+9.7%)
Mar 2005
-
$32.84M(+302.3%)
$37.44M(+714.5%)
Dec 2004
$4.60M(-64.5%)
$8.16M(<-9900.0%)
$4.60M(-229.6%)
Sep 2004
-
-$2000.00(-99.9%)
-$3.55M(-137.7%)
Jun 2004
-
-$3.57M(<-9900.0%)
$9.42M(-27.2%)
Mar 2004
-
$0.00(-100.0%)
$12.94M(-0.1%)
Dec 2003
$12.95M(+7518.2%)
$20.00K(-99.8%)
$12.95M(+0.0%)
Sep 2003
-
$12.96M(<-9900.0%)
$12.95M(<-9900.0%)
Jun 2003
-
-$42.00K(-481.8%)
-$14.00K(-108.6%)
Mar 2003
-
$11.00K(-35.3%)
$163.00K(-4.1%)
Dec 2002
$170.00K(+11.1%)
$17.00K(>+9900.0%)
$170.00K(-13.7%)
Sep 2002
-
$0.00(-100.0%)
$197.00K(-13.2%)
Jun 2002
-
$135.00K(+650.0%)
$227.00K(+54.4%)
Mar 2002
-
$18.00K(-59.1%)
$147.00K(-3.9%)
Dec 2001
$153.00K(-99.8%)
$44.00K(+46.7%)
$153.00K(-99.7%)
Sep 2001
-
$30.00K(-45.5%)
$60.75M(-0.3%)
Jun 2001
-
$55.00K(+129.2%)
$60.91M(-35.3%)
Mar 2001
-
$24.00K(-100.0%)
$94.07M(-3.4%)
Dec 2000
$97.37M(>+9900.0%)
$60.64M(>+9900.0%)
$97.37M(+165.1%)
Sep 2000
-
$185.00K(-99.4%)
$36.73M(+0.5%)
Jun 2000
-
$33.22M(+900.0%)
$36.54M(+999.7%)
Mar 2000
-
$3.32M(>+9900.0%)
$3.32M(>+9900.0%)
Dec 1999
$312.00K
-
-
Jun 1999
-
$1000.00(>+9900.0%)
$1000.00(>+9900.0%)
Mar 1999
-
$0.00
$0.00

FAQ

  • What is Insmed Incorporated annual cash flow from financing activities?
  • What is the all time high annual CFF for Insmed Incorporated?
  • What is Insmed Incorporated annual CFF year-on-year change?
  • What is Insmed Incorporated quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Insmed Incorporated?
  • What is Insmed Incorporated quarterly CFF year-on-year change?
  • What is Insmed Incorporated TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Insmed Incorporated?
  • What is Insmed Incorporated TTM CFF year-on-year change?

What is Insmed Incorporated annual cash flow from financing activities?

The current annual CFF of INSM is $1.34B

What is the all time high annual CFF for Insmed Incorporated?

Insmed Incorporated all-time high annual cash flow from financing activities is $1.34B

What is Insmed Incorporated annual CFF year-on-year change?

Over the past year, INSM annual cash flow from financing activities has changed by +$1.17B (+696.15%)

What is Insmed Incorporated quarterly cash flow from financing activities?

The current quarterly CFF of INSM is $29.00M

What is the all time high quarterly CFF for Insmed Incorporated?

Insmed Incorporated all-time high quarterly cash flow from financing activities is $781.49M

What is Insmed Incorporated quarterly CFF year-on-year change?

Over the past year, INSM quarterly cash flow from financing activities has changed by +$25.98M (+859.56%)

What is Insmed Incorporated TTM cash flow from financing activities?

The current TTM CFF of INSM is $1.37B

What is the all time high TTM CFF for Insmed Incorporated?

Insmed Incorporated all-time high TTM cash flow from financing activities is $1.37B

What is Insmed Incorporated TTM CFF year-on-year change?

Over the past year, INSM TTM cash flow from financing activities has changed by +$1.20B (+695.41%)
On this page